TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Community Paramedicine Initiative for Older Adults Living in Subsidized Housing (CHAP-EMS/Renamed to CP@Clinic)
Brief Summary: Older adults living in subsidized housing report poorer health. Their age and low income make it harder for them to use community services. Many older adults have heart disease and diabetes, which lead to frequent emergency calls and hospital admissions. To decrease the costs of treating heart disease and diabetes through emergency and hospitalization, improved screening and health education is needed. Our program will take place in communal areas within housing buildings of older adults and deliver a heart disease, diabetes, and falls risk check-up with health education. This is expected to improve the health of older adults leading to fewer emergency calls and hospital visits.


Options:
A: Arm Label: Psychoeducative intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Psychoeducative intervention | Arm Label: Usual care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Psychoeducative intervention; Assigned to Arm(s): Psychoeducative intervention
B: Arm Label: Diabetes-Specific CBT (DS-CBT); Type: EXPERIMENTAL; Interventions: Behavioral: Diabetes-Specific CBT (DS-CBT) | Arm Label: Standard Diabetes Education; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Standard Diabetes Education | Intervention Type: BEHAVIORAL; Name: Diabetes-Specific CBT (DS-CBT); Assigned to Arm(s): Diabetes-Specific CBT (DS-CBT) | Intervention Type: BEHAVIORAL; Name: Standard Diabetes Education; Assigned to Arm(s): Standard Diabetes Education
C: Arm Label: CHAP-EMS/CP@clinic Program Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: CHAP-EMS/CP@clinic | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: CHAP-EMS/CP@clinic; Assigned to Arm(s): CHAP-EMS/CP@clinic Program Intervention
D: Arm Label: Conventional care, controlgroup; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: integrated health care chain; Type: EXPERIMENTAL; Interventions: Other: integrated health care chain | Intervention Type: OTHER; Name: integrated health care chain; Assigned to Arm(s): integrated health care chain

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Community Paramedicine Initiative for Older Adults Living in Subsidized Housing (CHAP-EMS/Renamed to CP@Clinic)
Brief Summary: Older adults living in subsidized housing report poorer health. Their age and low income make it harder for them to use community services. Many older adults have heart disease and diabetes, which lead to frequent emergency calls and hospital admissions. To decrease the costs of treating heart disease and diabetes through emergency and hospitalization, improved screening and health education is needed. Our program will take place in communal areas within housing buildings of older adults and deliver a heart disease, diabetes, and falls risk check-up with health education. This is expected to improve the health of older adults leading to fewer emergency calls and hospital visits.


Options:
A: Arm Label: SSRI + placebo; Type: ACTIVE_COMPARATOR; Interventions: Drug: SSRI + placebo | Arm Label: Escitalopram + Bupropion SR; Type: ACTIVE_COMPARATOR; Interventions: Drug: Escitalopram + Bupropion SR | Arm Label: Venlafaxine XR + Mirtazapine; Type: ACTIVE_COMPARATOR; Interventions: Drug: Venlafaxine XR + Mirtazapine | Intervention Type: DRUG; Name: SSRI + placebo; Assigned to Arm(s): SSRI + placebo | Intervention Type: DRUG; Name: Escitalopram + Bupropion SR; Assigned to Arm(s): Escitalopram + Bupropion SR | Intervention Type: DRUG; Name: Venlafaxine XR + Mirtazapine; Assigned to Arm(s): Venlafaxine XR + Mirtazapine
B: Arm Label: Nurse case management and self-management support; Type: EXPERIMENTAL; Interventions: Other: Nurse case management and self-management support | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Nurse case management and self-management support; Assigned to Arm(s): Nurse case management and self-management support
C: Arm Label: Auto DAS; Type: EXPERIMENTAL; Interventions: Behavioral: Auto-DAS | Arm Label: Comorbidities treatment; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Comorbidities treatment | Intervention Type: BEHAVIORAL; Name: Comorbidities treatment; Assigned to Arm(s): Comorbidities treatment | Intervention Type: BEHAVIORAL; Name: Auto-DAS; Assigned to Arm(s): Auto DAS
D: Arm Label: CHAP-EMS/CP@clinic Program Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: CHAP-EMS/CP@clinic | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: CHAP-EMS/CP@clinic; Assigned to Arm(s): CHAP-EMS/CP@clinic Program Intervention

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Multicentric Randomized Clinical Trial to Evaluate the Long-term Effectiveness of a Motivational Intervention Against Smoking, Based on the Information Obtained From Spirometry in Primary Care.
Brief Summary: There is controversy about the effectiveness of interventions based on spirometry for smoking cessation.

The investigators want to evaluate the effectiveness of motivational intervention performed by a doctor to obtain abstinence compared with normal practice in primary care.

This study, is the second half of what was began with ESPITAP study


Options:
A: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: motivational counseling | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: placebo | Intervention Type: BEHAVIORAL; Name: motivational counseling; Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: placebo; Assigned to Arm(s): 2
B: Arm Label: Spirometry and lifestyle counseling; Type: EXPERIMENTAL; Interventions: Behavioral: Smoking cessation advice, Behavioral: Spirometry and smoking cessation advice | Arm Label: Lifestyle counseling; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Smoking cessation advice; Assigned to Arm(s): Spirometry and lifestyle counseling | Intervention Type: BEHAVIORAL; Name: Spirometry and smoking cessation advice; Assigned to Arm(s): Spirometry and lifestyle counseling
C: Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Respiragene test and risk score; Type: EXPERIMENTAL; Interventions: Genetic: Respiragene test and risk score | Intervention Type: GENETIC; Name: Respiragene test and risk score; Assigned to Arm(s): Respiragene test and risk score
D: Arm Label: Spirometry; Type: EXPERIMENTAL; Interventions: Behavioral: Spirometry | Arm Label: Brief smoking cessation advice; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Spirometry; Assigned to Arm(s): Spirometry

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Pilot, Double-blind, Placebo-controlled, 2-period Crossover Study to Assess the Effect of Aclidinium Bromide 400 μg Bid on COPD Symptoms and Sleep Quality After 3 Weeks of Treatment in Patients With Stable Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD)
Brief Summary: The purpose of this study is to assess the effect of aclidinium bromide compared with placebo in improving dilatation of the airways (bronchodilation), symptoms of chronic obstructive pulmonary disease (COPD), sleep quality and physical activity after 3 weeks of treatment with aclidinium bromide 400 μg administered twice daily in patients with stable moderate-and-severe COPD.


Options:
A: Arm Label: Home-based pulmonary rehabilitation; Type: EXPERIMENTAL; Interventions: Behavioral: Home-based pulmonary rehabilitation | Arm Label: Hospital-based pulmonary rehabilitation; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Hospital-based pulmonary rehabilitation | Intervention Type: BEHAVIORAL; Name: Home-based pulmonary rehabilitation; Assigned to Arm(s): Home-based pulmonary rehabilitation | Intervention Type: BEHAVIORAL; Name: Hospital-based pulmonary rehabilitation; Assigned to Arm(s): Hospital-based pulmonary rehabilitation
B: Arm Label: Aclidinium bromide; Type: EXPERIMENTAL; Interventions: Drug: Aclidinium bromide | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Aclidinium bromide; Assigned to Arm(s): Aclidinium bromide | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
C: Arm Label: Control group; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Supervised COPD Rehabilitation (control group) | Arm Label: Online COPD rehabilitation; Type: EXPERIMENTAL; Interventions: Behavioral: Online COPD rehabilitation (experimental) | Intervention Type: BEHAVIORAL; Name: Supervised COPD Rehabilitation (control group); Assigned to Arm(s): Control group | Intervention Type: BEHAVIORAL; Name: Online COPD rehabilitation (experimental); Assigned to Arm(s): Online COPD rehabilitation
D: Arm Label: Tool + Self-management Support Program; Type: EXPERIMENTAL; Interventions: Device: Tool, Behavioral: Self-management Support Program | Arm Label: Self- management Support Program; Type: EXPERIMENTAL; Interventions: Behavioral: Self-management Support Program | Arm Label: Care as usual; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Tool; Assigned to Arm(s): Tool + Self-management Support Program | Intervention Type: BEHAVIORAL; Name: Self-management Support Program; Assigned to Arm(s): Self- management Support Program, Tool + Self-management Support Program

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Initial Efficacy Study of Supporting Play, Exploration, & Early Development Intervention (SPEEDI) - Phase 1 Clinical Trial
Brief Summary: The primary aims of this randomized controlled trial are to evaluate efficacy potential of SPEEDI at enhancing reaching and play based problem solving compared to infants receiving usual care.


Options:
A: Arm Label: Usual Care Group; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: SPEEDI Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: SPEEDI Intervention | Intervention Type: BEHAVIORAL; Name: SPEEDI Intervention; Assigned to Arm(s): SPEEDI Intervention
B: Arm Label: MT during and after NICU; Type: EXPERIMENTAL; Interventions: Behavioral: MT during NICU, Behavioral: MT after NICU, Other: Standard care | Arm Label: MT during NICU; Type: EXPERIMENTAL; Interventions: Behavioral: MT during NICU, Other: Standard care | Arm Label: MT after NICU; Type: EXPERIMENTAL; Interventions: Behavioral: MT after NICU, Other: Standard care | Arm Label: No MT; Type: EXPERIMENTAL; Interventions: Other: Standard care | Intervention Type: BEHAVIORAL; Name: MT during NICU; Assigned to Arm(s): MT during NICU, MT during and after NICU | Intervention Type: BEHAVIORAL; Name: MT after NICU; Assigned to Arm(s): MT after NICU, MT during and after NICU | Intervention Type: OTHER; Name: Standard care; Assigned to Arm(s): MT after NICU, MT during NICU, MT during and after NICU, No MT
C: Arm Label: Early stimulation; Type: EXPERIMENTAL; Interventions: Other: Early stimulation | Arm Label: Conventional care; Type: ACTIVE_COMPARATOR; Interventions: Other: Conventional care | Intervention Type: OTHER; Name: Early stimulation; Assigned to Arm(s): Early stimulation | Intervention Type: OTHER; Name: Conventional care; Assigned to Arm(s): Conventional care
D: N/A

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effect of Injectable Intracervical Anesthesia on the Pain Associated With the Insertion of the Levonorgestrel-releasing Intrauterine System in Women Without Previous Vaginal Delivery: a Randomized Controlled Trial
Brief Summary: This study has the objective to evaluate the effect of Injectable intracervical anesthesia in comparison with a non-steroidal anti-inflammatory drug (NSAID) on the pain scores immediately after insertion of the levonorgestrel-releasing intrauterine system (LNG-IUS) in women without previous vaginal delivery.

H0: There is no difference in terms of pain score between the treatments H1: There will be difference in terms of pain score between treatments


Options:
A: Arm Label: lidocaine gel; Type: EXPERIMENTAL; Interventions: Drug: 2% lidocaine gel | Arm Label: placebo gel (surgilube); Type: PLACEBO_COMPARATOR; Interventions: Other: placebo | Intervention Type: DRUG; Name: 2% lidocaine gel; Assigned to Arm(s): lidocaine gel | Intervention Type: OTHER; Name: placebo; Assigned to Arm(s): placebo gel (surgilube)
B: Arm Label: misoprostol; Type: EXPERIMENTAL; Interventions: Drug: Misoprostol | Arm Label: placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Misoprostol; Assigned to Arm(s): misoprostol | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): placebo
C: Arm Label: Oxygen (Placebo); Type: PLACEBO_COMPARATOR; Interventions: Procedure: IUD insertion, Drug: Povidone-Iodine, Drug: Chlorhexidine, Other: Oxygen | Arm Label: Nitrous Oxide (NO); Type: EXPERIMENTAL; Interventions: Procedure: IUD insertion, Drug: Povidone-Iodine, Drug: Chlorhexidine, Other: Nitrous oxide | Intervention Type: PROCEDURE; Name: IUD insertion; Assigned to Arm(s): Nitrous Oxide (NO), Oxygen (Placebo) | Intervention Type: DRUG; Name: Povidone-Iodine; Assigned to Arm(s): Nitrous Oxide (NO), Oxygen (Placebo) | Intervention Type: DRUG; Name: Chlorhexidine; Assigned to Arm(s): Nitrous Oxide (NO), Oxygen (Placebo) | Intervention Type: OTHER; Name: Oxygen; Assigned to Arm(s): Oxygen (Placebo) | Intervention Type: OTHER; Name: Nitrous oxide; Assigned to Arm(s): Nitrous Oxide (NO)
D: Arm Label: intracervical anesthesia; Type: ACTIVE_COMPARATOR; Interventions: Drug: Intracervical anesthesia with lidocaine 2% | Arm Label: ibuprofen; Type: ACTIVE_COMPARATOR; Interventions: Drug: ibuprofen 400 mg | Intervention Type: DRUG; Name: Intracervical anesthesia with lidocaine 2%; Assigned to Arm(s): intracervical anesthesia | Intervention Type: DRUG; Name: ibuprofen 400 mg; Assigned to Arm(s): ibuprofen

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomised, Double-blind, Double Dummy, 56 Week Placebo-controlled, Multicentre, Parallel Group, Phase 3 Study Evaluating Efficacy/Safety of 3 Benralizumab Doses in Patients With Moderate to Very Severe COPD With Previous Exacerbations.
Brief Summary: The purpose of the study is to determine if benralizumab reduces COPD exacerbation rate in symptomatic patients with moderate to very severe COPD who are receiving standard of care therapies.


Options:
A: Arm Label: COPD subjects; Type: N/A; Interventions: Other: Novel endpoint determination | Arm Label: Smoker controls; Type: N/A; Interventions: Other: Novel endpoint determination | Arm Label: Non-smoker controls; Type: N/A; Interventions: Other: Novel endpoint determination | Intervention Type: OTHER; Name: Novel endpoint determination; Assigned to Arm(s): COPD subjects, Non-smoker controls, Smoker controls
B: Arm Label: Arm 1; Type: EXPERIMENTAL; Interventions: Drug: Mepolizumab | Arm Label: Arm 2; Type: EXPERIMENTAL; Interventions: Drug: Mepolizumab | Arm Label: Arm 3; Type: EXPERIMENTAL; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Mepolizumab; Assigned to Arm(s): Arm 1, Arm 2 | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Arm 3
C: Arm Label: Benralizumab Arm A; Type: EXPERIMENTAL; Interventions: Drug: Benralizumab Arm A | Arm Label: Benralizumab Arm B; Type: EXPERIMENTAL; Interventions: Drug: Benralizumab Arm B | Arm Label: Benralizumab Arm C; Type: EXPERIMENTAL; Interventions: Drug: Benralizumab Arm C | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Benralizumab Arm A; Assigned to Arm(s): Benralizumab Arm A | Intervention Type: DRUG; Name: Benralizumab Arm B; Assigned to Arm(s): Benralizumab Arm B | Intervention Type: DRUG; Name: Benralizumab Arm C; Assigned to Arm(s): Benralizumab Arm C | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
D: Arm Label: Eosinophilic phenotype (EOS+) Placebo; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo | Arm Label: EOS+ Benralizumab (2 mg); Type: EXPERIMENTAL; Interventions: Biological: Benralizumab 2 mg | Arm Label: EOS+ Benralizumab (20 mg); Type: EXPERIMENTAL; Interventions: Biological: Benralizumab 20 mg | Arm Label: EOS+ Benralizumab (100 mg); Type: EXPERIMENTAL; Interventions: Biological: Benralizumab 100 mg | Arm Label: Non-eosinophil phenotype (EOS-) Placebo; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo | Arm Label: EOS- Benralizumab (100 mg); Type: EXPERIMENTAL; Interventions: Biological: Benralizumab 100 mg | Intervention Type: BIOLOGICAL; Name: Benralizumab 2 mg; Assigned to Arm(s): EOS+ Benralizumab (2 mg) | Intervention Type: BIOLOGICAL; Name: Benralizumab 20 mg; Assigned to Arm(s): EOS+ Benralizumab (20 mg) | Intervention Type: BIOLOGICAL; Name: Benralizumab 100 mg; Assigned to Arm(s): EOS+ Benralizumab (100 mg), EOS- Benralizumab (100 mg) | Intervention Type: OTHER; Name: Placebo; Assigned to Arm(s): Eosinophilic phenotype (EOS+) Placebo, Non-eosinophil phenotype (EOS-) Placebo

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Case Management for Underserved Hispanic Type 2 Diabetes Populations
Brief Summary: To compare a comprehensive diabetes team care condition (IC) involving the diabetes team's use of a "diabetes dashboard" with a usual diabetes team care condition (UDC) that does not have access to the diabetes dashboard.


Options:
A: Arm Label: 1; Type: OTHER; Interventions: Behavioral: Cognitive Behavioral Intervention | Arm Label: 2; Type: OTHER; Interventions: Behavioral: Office System Redesign Intervention | Arm Label: 3; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Cognitive Behavioral Intervention; Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: Office System Redesign Intervention; Assigned to Arm(s): 2
B: Arm Label: MEDIC; Type: EXPERIMENTAL; Interventions: Behavioral: Behavioral counseling and peer support, Behavioral: Interactive Education, Behavioral: Role modeling, Procedure: Pharmacologic case management | Arm Label: usual care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Behavioral counseling and peer support; Assigned to Arm(s): MEDIC | Intervention Type: BEHAVIORAL; Name: Interactive Education; Assigned to Arm(s): MEDIC | Intervention Type: BEHAVIORAL; Name: Role modeling; Assigned to Arm(s): MEDIC | Intervention Type: PROCEDURE; Name: Pharmacologic case management; Assigned to Arm(s): MEDIC
C: Arm Label: dashboard team care intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Diabetes Dashboard Intervention | Arm Label: usual diabetes team control; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Usual Diabetes Care | Intervention Type: BEHAVIORAL; Name: Diabetes Dashboard Intervention; Assigned to Arm(s): dashboard team care intervention | Intervention Type: BEHAVIORAL; Name: Usual Diabetes Care; Assigned to Arm(s): usual diabetes team control
D: Arm Label: Information on community resources; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Community Health Worker services; Type: EXPERIMENTAL; Interventions: Behavioral: Community Health Worker (CHW) services | Intervention Type: BEHAVIORAL; Name: Community Health Worker (CHW) services; Assigned to Arm(s): Community Health Worker services

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Case Management for Underserved Hispanic Type 2 Diabetes Populations
Brief Summary: To compare a comprehensive diabetes team care condition (IC) involving the diabetes team's use of a "diabetes dashboard" with a usual diabetes team care condition (UDC) that does not have access to the diabetes dashboard.


Options:
A: Arm Label: 1; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Procedure: Computer-Assisted Decision Support | Intervention Type: PROCEDURE; Name: Computer-Assisted Decision Support; Assigned to Arm(s): 2
B: Arm Label: dashboard team care intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Diabetes Dashboard Intervention | Arm Label: usual diabetes team control; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Usual Diabetes Care | Intervention Type: BEHAVIORAL; Name: Diabetes Dashboard Intervention; Assigned to Arm(s): dashboard team care intervention | Intervention Type: BEHAVIORAL; Name: Usual Diabetes Care; Assigned to Arm(s): usual diabetes team control
C: Arm Label: Trained Clinicians; Type: EXPERIMENTAL; Interventions: Behavioral: Training | Arm Label: Non-trained Clinicians; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Non-volunteer Clinicians; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Training; Assigned to Arm(s): Trained Clinicians
D: Arm Label: Electronic alert; Type: ACTIVE_COMPARATOR; Interventions: Other: Electronic warning alert | Arm Label: No electronic alert; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Electronic warning alert; Assigned to Arm(s): Electronic alert

Answer: B